Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PRTK - Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale

PRTK - Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale

Paratek Pharmaceuticals Inc.
  • Nuzyra launch trajectory is top of class compared with other antibiotics.
  • BARDA deal signed late 2019 is worth $285M.
  • If things go even slightly right for the company, it could easily be a 5-bagger in a few years.
  • No dilution in sight which is refreshing for a biotech.

For further details see:

Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale
Stock Information
Company Name: Paratek Pharmaceuticals Inc.
Stock Symbol: PRTK
Market: NASDAQ
Website: paratekpharma.com
Menu
PRTK PRTK Quote PRTK Short PRTK News PRTK Articles PRTK Message Board
Get PRTK Alerts

News, Short Squeeze, Breakout and More Instantly...